HomeRDY • NYSE
Dr Reddy's Laboratories Ltd
Follow
$83.20
After Hours: $83.20
Closed: Aug 2, 5:16:17 PM GMT-4 · USD · NYSE · Disclaimer
Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements
HDFC Bank Ltd
$60.00
HDB0.84%
Infosys Ltd ADR
$21.77
INFY2.38%
Wipro Ltd
$5.92
WIT2.95%
ICICI Bank Ltd
$28.11
IBN2.36%
Sify Technologies Limited
$0.39
SIFY1.05%
WNS (Holdings) Ltd
$57.62
WNS1.61%
Makemytrip Ltd
$84.89
MMYT5.14%
Pfizer Inc
$30.43
PFE0.72%
Yatra Online Inc
$1.33
YTRA4.32%
Dynasty Metals & Mining
$0.45
TTM0.00%
Top news
By the numbers
Financials
Income Statement
Revenue Net income Fiscal Q1 2025 ended 6/30/24. Reported on 7/26/24. Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations Operating expense Represents the total incurred expenses through normal operations Net income Company’s earnings for a period net of operating costs, taxes, and interest Net profit margin Measures how much net income or profit is generated as a percentage of revenue. Earnings per share Represents the company's profit divided by the outstanding shares of its common stock. EBITDA Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances Effective tax rate The percent of their income that a corporation pays in taxes(INR) Jun 2024info Y/Y change 76.73B 13.87% 28.40B 29.68% 13.92B -0.75% 18.14 -12.83% 83.48 -0.94% 21.76B 2.51% 26.04% —
Balance Sheet
Total assets Total liabilities Fiscal Q1 2025 ended 6/30/24. Reported on 7/26/24. Cash and short-term investments Investments that are relatively liquid and have maturities between 3 months and one year Total assets The total amount of assets owned by a company Total liabilities Sum of the combined debts a company owes Total equity The value of subtracting the total liabilities from the total assets of a company Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing Price to book A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock Return on assets A financial ratio that shows a company’s profitability compared to its assets Return on capital Company’s return above the average cost it pays for its debt and equity capital(INR) Jun 2024info Y/Y change 94.63B 57.03% 415.30B 23.95% 120.67B 34.40% 294.63B — 166.55M — 0.05 — 11.18% — 14.34% —
Cash Flow
Net change in cash Fiscal Q1 2025 ended 6/30/24. Reported on 7/26/24. Net income Company’s earnings for a period net of operating costs, taxes, and interest Cash from operations Net cash used or generated for core business activities Cash from investing Net cash used or generated in investing activities such as purchasing assets Cash from financing Net cash used or generated in financing activities such as dividend payments and loans Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period Free cash flow Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments(INR) Jun 2024info Y/Y change 13.92B -0.75% 8.50B -24.48% -20.25B -145.85% 9.54B 746.41% -2.19B -251.41% -301.88M 94.61%
US listed security Listed on NYSE Headquartered in Hyderabad, Andhra Pradesh, India
Previous close The last closing price
$82.53
Day range The range between the high and low prices over the past day
$81.99 - $83.25
Year range The range between the high and low prices over the past 52 weeks
$63.72 - $83.25
Market cap A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
13.82B USD
Avg Volume The average number of shares traded each day over the past 30 days
255.62K
CDP Climate Change Score A score provided by CDP (formerly the Carbon Disclosure Project) that rates a company on its climate transparency and performance
A-
About
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.By 2007, Dr. Wikipedia CEO Erez Israeli Founded 1984 Headquarters Hyderabad, Andhra PradeshIndia Website Employees 27,048
